Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/28/2021
KoBioLabs Announces Licensing Deal with SPH SINE for KBL697 and KBL693...
10/28/2021
Novo Nordisk's Xultophy Insulin (degludec/liraglutide) Wins Chinese Ap...
10/28/2021
HUYABIO Cleared P1 Trial of SHP2 Inhibitor for KRAS and EGFR Mutated T...
10/27/2021
Boehringer Ingelheim Submits Chinese NDA for First-in-class Spesolimab...
10/27/2021
Fosun to Take on Pfizer's Prevnar with Acquisition of Antejin Biotech
10/27/2021
Jemincare Group Accuses China Bohai Bank of Misusing Its CNY 2.8B Depo...
10/26/2021
PhIIC's China Generic Drug Bluebook 2021: Up 3.9% in 2019 but Down 16....
10/26/2021
Angel Pharma Announces Chinese IND Approval for ITK Inhibitor CPI-818
10/26/2021
I-Mab Enters Strategic Partnership with Sinopharm for Launch of its I...
10/26/2021
WHO Clears Chinese HPV Vaccine in Global Battle against Cervical Cance...
10/26/2021
SciNeuro and Mabylon to Co-develop Novel Therapeutics for Neurological...
10/26/2021
Merck unveils first innovation collaboration site open to startups
10/26/2021
How China Turned the Tables on Biopharma's Global Dealmaking: Endpoint
10/26/2021
Angel Pharma Announces Chinese IND Approval for ITK Inhibitor CPI-818
10/25/2021
CDE Publicizes the List of Reference Formulations for GQCE Studies (51...
10/25/2021
111, Inc. and Chugai Pharma Enter Strategic Partnership With to Acce...
10/25/2021
CANbridge Enters Global Licensing Pact with Scriptr Global to Develop...
10/25/2021
Novartis's NDA for Ribociclib Accepted in China
10/25/2021
IQVIA Unveils Comprehensive Analysis of Chinese Retail Pharmacy Market
10/22/2021
Antengene to Join Hands with LegoChem Biosciences for Research of New...
10/22/2021
NeoCura and MDimune Settle CDVs-mediated mRNA Collaboration
10/22/2021
I-Mab Opens New R&D Lab in San Diego
10/22/2021
China's MOFCOM Pledges Foreign Investment Expansion as It Plans to Ste...
10/22/2021
Recent Executive Moves
10/22/2021
SCMP: U.S. Warns American Firms to Protect Five Key Technologies
10/22/2021
Reuters: EU Plans Stricter Drugs Supply Rules to Avoid Reliance on 'Au...
10/21/2021
NMPA Issues the List of Reference Formulations for GQCE Studies (46th ...
10/21/2021
NMPA Issues the List of Reference Formulations for GQCE Studies (47th ...
10/21/2021
Luoxin Enters Licensing Deal With Austria-Based Marinomed Biotech for ...
10/21/2021
Ligand and CR Double-Crane Enter Deal to Develop an Oral COVID-19 Ther...
Page:
164
/
774
Total number of articles:
23207
:
[First]
[<<]
[162]
[163]
[164]
[165]
[166]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit